Abstract:Introduction: Chronic obstructive pulmonary disease (COPD) is a chronic respiratory disease with high prevalence and mortality. In some acute exacerbations of COPD (AECOPD) in patients with no obvious signs of infection, early antibiotic treatment seems to clinically improve the disease, but more studies are needed to determine the prognostic impact of antibiotic treatment in AECOPD patients with no obvious signs of infection. Purpose: To clarify the impact of antibiotic treatment on the short-term and long-term prognoses of AECOPD patients without obvious signs of infection. Methods: The impact of the two treatment methods on the prognosis of patients was compared at 30, 90, 180, and 360 days after discharge. A multicenter, randomized, parallel-controlled clinical trial was conducted in a department of respiratory and critical care medicine in Central China. All patients met the inclusion criteria for AECOPD, and the patients were randomly assigned to the antibiotic group or the nonantibiotic group at a 1:1 ratio. Patients in the antibiotic group were given moxifloxacin 400 mg/day intravenously for 7 days. Patients in the nonantibiotic group were intravenously injected with the same amount of normal saline as the amount of moxifloxacin given to those in the antibiotic group for 7 days. Results: There were 406 patients in the antibiotic group and 410 patients in the nonantibiotic group. During the short-term and long-term follow-ups, the acute exacerbation frequency, intensive care unit (ICU) treatment rate, mortality, and mMRC and CAT scores were not significantly different between the two groups ( p > 0.05). At the 180- and 360-day follow-ups, the forced expiratory volume in 1 s (FEV1%) and peak expiratory flow (PEF) were not significantly different between the two groups ( p > 0.05). The 30-day readmission rate was significantly lower in the antibiotic group than in the nonantibiotic group ( p < 0.05). The time from discharge to the first acute exacerbation was not significantly different between the two groups ( p > 0.05). The length of the first hospital stay after discharge was significantly lower in the antibiotic group (5.84 days) than in the nonantibiotic group (6.75 days) ( p < 0.05). At the 30-day follow-up, the acute exacerbation frequency, age, C-reactive protein (CRP) level, and sputum viscosity were significantly greater in the nonantibiotic group than in the antibiotic group ( p 62.5 years, with a CRP level >12.56 mg/L or with a sputum viscosity >III, in the nonantibiotic group than in those in the antibiotic group, suggesting that the short-term prognosis was poor. Conclusion: Patients who are >62.5 years of age, have a CRP concentration >12.56 mg/L, or have a sputum viscosity >III without obvious signs of infection should be treated with antibiotics to improve their short-term prognosis. Clinical Trial Registration:: (https://www.chictr.org.cn), (ChiCTR1800018921)

Infection and antibiotic therapy in patients with respiratory failure

Effect of bronchoalveolar lavage on the use of antibiotics in patients with severe pneumonia

Causative Agent Distribution and Antibiotic Therapy Assessment among Adult Patients with Community Acquired Pneumonia in Chinese Urban Population.

Explore Rational Use of Antibacterials on Higher Level by Comparative Analysis of Antibacterials Used for Respiratory Infection before and in Hospitalization

Characterization of respiratory bacterial co-infection and assessment of empirical antibiotic treatment in patients with COVID-19 at hospital admission

The use of antibiotics in the early stage of acute exacerbation of chronic obstructive pulmonary disease in patients without obvious signs of infection: a multicenter, randomized, parallel-controlled study

[Bacterial resistance and antimicrobial therapy in respiratory medicine and intensive care]

Selection and Application Opportunity of Antibiotics in Children with Respiratory Tract Infections

Changes of pathogens and antibiotic susceptibility surveillance in a respiratory ward from 2001 to 2005

Clinical Effect of Antibiotic Therapy in The Treatment of Severe Pneumonia in Elderly Patients

Elderly patients with concurrent hip fracture and lower respiratory tract infection: the pathogens and prognosis over different bedridden periods

THE USE OF EMPIRICAL ANTIBIOTICS IN THE CRITICAL CARE UNIT

Antibiotic Application in Elderly Inpatients:A Comparative Analysis

Clinical Investigation of Pathogens and Their Drug Resistance in Senile Patients with Lower Respiratory Tract Infection in Intensive Care Unit

Distribution and Antibiotic Resistance of Isolates from Lower Respiratory Tract in Mechanically Ventilated Patients with COPD

[The Impact of Antibiotic Treatment in Patients with Influenza-Like Illness].

Investigation on Nosocomial Infections in Paralytic Patients and Exploration of Antibiotics Therapy

Antibiotic Application in Beijing Friendship Hospital, 2004:An Investigation

Current Concepts in Community and Ventilator Associated Lower Respiratory Tract Infections in ICU Patients

Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study

Antibiotic Treatment of Pulmonary Infections: An Umbrella Review and Evidence Map